Navigation Links
US Fermenters Market to Reach $180 million by 2015, According to New Report by Global Industry Analysts, Inc.
Date:2/22/2010

GIA announces the release of a US report on Fermenters market. The US market for fermenters is projected to reach $180 million by the year 2015. Growth in the market is being driven by increasing demand for biological drugs worldwide, and growing use of disposable or single-use fermenters.

San Jose, California (PRWEB) February 22, 2010 -- Fermenters are witnessing sizeable growth in demand, driven by increased development and production of biological drugs. Growth is being fuelled by increasing penetration of biological drugs in the global pharmaceutical market. However, increase in the overall fermentation capacity is expected to be sluggish, due in part to improving manufacturing processes that is enabling yield improvement at a given capacity.

Stainless steel tanks continue to dominate the fermenters market, as stated by the new market research report on Fermenters market. Key factors fuelling the continued presence of stainless steel tanks are high mixing speed, high cell concentrations, and short runs. However, the conventional stainless steel fermenter systems are making way for disposable components, which offer cost efficiency and timesavings. In response to this, manufacturers of fermenters are offering disposable fermenters or single-use fermenters. Disposable fermenters provide significant benefits, such as minimized operational times, reduction in plant validation, and enhanced flexibility.

In recent years, the fermenter industry became highly competitive, owing to the entry of several new players into the market. This was fuelled by substantial growth in the global biotech drugs sector. Select players profiled in the report include ABEC Inc., Applikon Biotechnology Inc., Bioengineering AG, Cole-Parmer Instrument Company, Lofstrand Labs Limited, New Brunswick Scientific Co. Inc., and Sartorius AG.

The report titled "Fermenters: A US Market Report" announced by Global Industry Analysts Inc., provides a strategic review of market dynamics, market trends, product details, product introductions/innovations, corporate initiatives, and competitive intelligence. The study analyzes market data and analytics in terms of value sales for the US market.

For more details about this comprehensive market research report, please visit - http://www.strategyr.com/Fermenters_Market_Report.asp

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs over 800 people worldwide and publishes more than 1100 full-scale research reports each year. Additionally, the company also offers thousands of smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.

Global Industry Analysts, Inc.
Telephone 408-528-9966
Fax 408-528-9977
Email press(at)StrategyR(dot)com
Web Site http://www.StrategyR.com/

###

Read the full story at http://www.prweb.com/releases/fermenters/disposable_mammalian_cell/prweb3629854.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Waters and DAISO Sign Marketing Agreement for Bulk Process Chromatography Media
2. Reportlinker Adds the Clinical Laboratory Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles)
3. Reportlinker Adds SNP Genotyping and Analysis Markets
4. United Therapeutics Corporation to Announce Fourth Quarter and Annual 2009 Financial Results Before Market Open on Tuesday, February 16, 2010
5. RURO and Brady Team to Deliver Solutions for Mid-market Laboratory Applications
6. EUCODIS Bioscience Receives EUR 2 Million Cash Injection to Enlarge Product Portfolio and Develop International Markets
7. SynCo Bio Partners Signs New Manufacturing Agreements to Supply the US Market; Securing its Position as a Market Leader in Microbial Biopharmaceutical Contract Production
8. BioSpec Global Solutions Inc, takes delivery of new TOGs 3000 Home edition for the U.S. and international markets
9. China Yongxin Pharmaceuticals Plans to Open Eighteen New Stores in 2010 to Further Expand Customer Base and Increase Market Share
10. VirtualHealth Technologies Will Change Its Name to VHGI Holdings, Inc. and Surges Forward Into Broader Market
11. InfoSpi to Create $500m Green Hedge Fund Focusing on the Carbon Credit Market
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
US Fermenters Market to Reach $180 million by 2015, According to New Report by Global Industry Analysts, Inc. 
(Date:10/11/2017)... ... October 11, 2017 , ... At ... Purple announced Dr. Suneel I. Sheikh, the co-founder, CEO and chief research scientist ... has been selected for membership in ARCS Alumni Hall of Fame . ...
(Date:10/11/2017)... ... ... a basic first aid supply for any work environment, but most personal eye wash can ... a dangerous substance enters both eyes? It’s one less decision, and likely quicker response time ... , “Whether its dirt and debris, or an acid or alkali, getting anything in your ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... it will be hosting a Webinar titled, “Pathology is going digital. Is your ... on digital pathology adoption best practices and how Proscia improves lab economics and ...
(Date:10/11/2017)... Netherlands and LAGUNA HILLS, Calif. ... Institute of Cancer Research, London (ICR) ... MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients with ... known as MUK nine . The University of ... which is partly funded by Myeloma UK, and ICR will ...
Breaking Biology Technology:
(Date:4/5/2017)... , April 5, 2017  The Allen Institute for ... Cell Explorer: a one-of-a-kind portal and dynamic digital window ... imaging data, the first application of deep learning to ... stem cell lines and a growing suite of powerful ... for these and future publicly available resources created and ...
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/29/2017)... the health IT company that operates the largest health ... today announced a Series B investment from BlueCross BlueShield ... investment and acquisition accelerates higi,s strategy to create the ... activities through the collection and workflow integration of ambient ... secures data today on behalf of over 36 million ...
Breaking Biology News(10 mins):